Displaying drugs 14201 - 14225 of 14426 in total
Rivoglitazone
Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
Experimental
Investigational
4SC-203
4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
SC-74020
Experimental
BMS-394136
BMS-394136 has been used in trials studying the diagnostic of Heart Diseases.
Investigational
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
Experimental
Illicit
Embutramide
Experimental
Illicit
4-Bromo-2,5-dimethoxyphenethylamine
Experimental
Illicit
R048-8071
Experimental
N-Cyclohexyl-N'-(4-Iodophenyl)Urea
Experimental
N-Butyl-Benzenesulfonamide
Experimental
3,5-Difluorobenzenesulfonamide
Experimental
4-iodo-acetamido phenylboronic acid
Experimental
PASBN
Experimental
Displaying drugs 14201 - 14225 of 14426 in total